News Releases

09/24/20	Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist
09/03/20	Millendo Therapeutics to Participate in September Investor Conferences
08/10/20	Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results
08/05/20	Millendo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
06/23/20	Millendo Therapeutics Provides Corporate and Pipeline Update
05/08/20	Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results
04/06/20	Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)
03/11/20	Millendo Therapeutics Reports Full Year 2019 Operating and Financial Results
03/05/20	Millendo Therapeutics to Present at Upcoming Investor Conferences
02/18/20	Millendo Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference

News Releases

Shareholder Tools